Nursery Product-Related Injuries Treated in United States Emergency Departments

Christopher E Gaw1,2, Thiphalak Chounthirath1, Gary A Smith3,4,5

  • 1Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.

Pediatrics
|March 15, 2017
PubMed

Insights

Nursery product injuries in young children decreased until 2003 but have risen since, with falls and head injuries being common. Increased prevention efforts are needed for baby carriers, cribs, and strollers.

Area of Science:

  • Pediatric Safety
  • Public Health
  • Injury Epidemiology

Background:

  • Nursery products are essential for child care but can pose injury risks.
  • Understanding injury trends is crucial for effective prevention strategies.

Purpose of the Study:

  • To determine the epidemiology of injuries associated with nursery products among children under 3 years old treated in US emergency departments.

Main Methods:

  • Retrospective analysis of data from the National Electronic Injury Surveillance System (NEISS).
  • Inclusion of patients aged <3 years with nursery product-related injuries from 1991-2011.

Main Results:

  • Over 1.39 million nursery product-related injuries were treated in US emergency departments between 1991 and 2011.
  • Injury rates declined until 2003, then increased, driven by baby walker injuries initially and later by concussions/closed head injuries.
  • Baby carriers, cribs/mattresses, strollers/carriages, and baby walkers were the most common product associations; falls were the primary mechanism, with head/neck injuries being most frequent.

Conclusions:

  • While baby walker injuries decreased, overall nursery product injuries have risen since 2003.
  • Enhanced prevention efforts are necessary for baby carriers, cribs, and strollers.
  • Focusing on preventing falls and head injuries associated with nursery products is critical.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
95
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K